Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Dog Pound -- Ignore unavailable to you. Want to Upgrade?

To: Hank who wrote (4261)	10/8/1999 5:47:00 PM
From: DanZ	Read Replies (1) \| Respond to of 10293

Hank, I think my post on Yahoo is applicable to your comments. IF the clinical study concludes that Zicam prevents the common cold, I seriously doubt if GUMM would collapse like other stocks you referred to. If you think it would rally and then collapse, I'd like to know why. Stocks can collapse after a big rally if the rally was based on nonsensical hype. How can you classify a prevention for the common cold as nonsensical hype or a short squeeze? Of course, this is hypothetical, but investors have to plan for the worst case. messages.yahoo.com

To: Hank who wrote (4261)	10/8/1999 6:19:00 PM
From: Mike M	Read Replies (2) \| Respond to of 10293

I don't know that a huge short interest has always spelled doom for every stock that has ever been traded. All I know is that, in every case that I am aware of, this is an almost sure sign that a particular stock is doomed to fail eventually. Yahoo! and AMZN were difficult to short back in May 98, three splits ago. Both had huge short positions and modest floats.